The Surgeon

Using a combination of a targeted cancer-fighting agent called DFMO and a low dose of an anti-inflammatory drug, UC Irvine researchers have reduced the risk of reoccurring colorectal polyps, an early sign of colon cancer, by as much as 95 percent with fewer toxic side effects.

The study marks a breakthrough in the effort to combat colon cancer, the third leading cause of cancer in men and fourth in women, according to Dr. Frank L. Meyskens Jr., the Daniel G. Aldrich Chair at UC Irvine and director of its Chao Family Comprehensive Cancer Center.
(more…)

As our population ages and senior citizens become a larger demographic, cancer researchers are focusing on the links between aging and cancer. Studies presented at the 2008 Annual Meeting of the American Association for Cancer Research, April 12 – 16, highlight the biological aspects of aging that are key to greater risk and poorer prognosis, and surgical outcomes.
(more…)

Millions of post-menopausal women use hormone replacement therapy (HRT) as a method to reduce symptoms associated with menopause. In a recent University of Missouri study, researchers found that one of the hormones used in HRT, a synthetic progestin, could be a major factor in promoting breast cancer. At the same time, the researchers have compelling evidence that using an antibody that prevents new blood vessel formation in tumors, or a small molecular drug, known as PRIMA, with similar properties as the antibody may be effective in treating or preventing the negative effects of progestin.
(more…)

The world’s top laser experts will gather in Kissimmee, FL, to share innovations in lasers and emerging technologies at the 28th Annual Scientific Conference of the American Society for Laser Medicine and Surgery (ASLMS). “LASER 2008” will be held on April 2-6, 2008, at the Gaylord PalmsTM Resort and Convention Center. Headlining the scientific program are acknowledged leaders in the field who will unveil the latest research developments and clinical studies in laser medicine, as well as present promising devices poised to enhance disease detection and management.

The ASLMS conference is traditionally regarded as the premier forum for the introduction of the newest breakthroughs in laser diagnostics and technology. Accordingly, some of the research and techniques presented at the meeting are only in the early stages of development. In addition to nearly 2,000 laser specialists in aesthetic medicine, dermatology, ophthalmology, oncology, urology, gynecology and dentistry, about 160 industry exhibitors will be on hand to showcase their latest products.
(more…)